TRUE Private Wealth Advisors’s Gilead Sciences GILD Stock Holding History

TRUE Private Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Sell	1,925 -17	-0.9%	-$2.24K	0.02%	246
2026 Q1	$271K	Buy	1,942 +7	+0.4%	+$980	0.03%	228
2025 Q4	$238K	Buy	1,935 +61	+3%	+$7.41K	0.02%	236
2025 Q3	$208K	Hold	1,874	–	–	0.02%	254
2025 Q2	$208K	Sell	1,874 -161	-8%	-$17.1K	0.02%	238
2025 Q1	$228K	Buy	+2,035	New	+$210K	0.03%	216
2024 Q1	–	Sell	-2,572	Closed	-$208K	–	293
2023 Q4	$208K	Buy	+2,572	New	+$200K	0.03%	275
2023 Q2	–	Sell	-2,480	Closed	-$206K	–	246
2023 Q1	$206K	Hold	2,480	–	–	0.03%	218
2022 Q4	$213K	Buy	+2,480	New	+$196K	0.03%	206
2022 Q1	–	Sell	-3,143	Closed	-$228K	–	250
2021 Q4	$228K	Sell	3,143 -14	-0.4%	-$964	0.03%	238
2021 Q3	$220K	Buy	+3,157	New	+$222K	0.03%	221
2021 Q1	–	Sell	-35,581	Closed	-$2.07M	–	422
2020 Q4	$2.07M	Sell	35,581 -1,919	-5%	-$116K	0.35%	49
2020 Q3	$2.37M	Buy	37,500 +5,678	+18%	+$394K	0.4%	39
2020 Q2	$2.45M	Buy	31,822 +505	+2%	+$38.7K	0.45%	42
2020 Q1	$2.34M	Buy	31,317 +30,926	+7,909%	+$2.14M	0.5%	35
2019 Q4	$25K	Buy	+391	New	+$25.5K	﹤0.01%	451
2019 Q3	–	Sell	-291	Closed	-$19K	–	422
2019 Q2	$19K	Buy	+291	New	+$19.1K	﹤0.01%	461
2018 Q4	–	Sell	-2,255	Closed	-$174K	–	515
2018 Q3	$174K	Buy	+2,255	New	+$170K	0.02%	280
2018 Q1	–	Sell	-3,255	Closed	-$233K	–	232
2017 Q4	$233K	Buy	+3,255	New	+$247K	0.04%	199

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRUE Private Wealth Advisors's GILD Position: Q2 2026 in Review

TRUE Private Wealth Advisors reduced its Gilead Sciences (GILD) stake by 0.88% in Q2 2026, selling an estimated $2.24K and leaving 1,925 shares worth $243K. The position accounts for 0.02% of the portfolio, ranked #246.

TRUE Private Wealth Advisors first reported a position in GILD in Q4 2017 and has held it in 19 quarters since. The position peaked at $2.45M in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

TRUE Private Wealth Advisors held 1,925 shares of Gilead Sciences worth $243K as of Q2 2026.
TRUE Private Wealth Advisors sold 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
Gilead Sciences made up 0.02% of TRUE Private Wealth Advisors's portfolio in Q2 2026, its #246 holding.
TRUE Private Wealth Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 19 quarters since.
TRUE Private Wealth Advisors's Gilead Sciences position peaked at $2.45M in Q2 2020.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TRUE Private Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.